MARKET

FRNM

FRNM

Freenome, Inc.
NASDAQ
16.31
-0.59
-3.49%
After Hours: 16.50 +0.19 +1.16% 19:41 09/04 EDT
OPEN
16.40
PREV CLOSE
16.90
HIGH
17.18
LOW
16.06
VOLUME
622.01K
TURNOVER
--
52 WEEK HIGH
17.18
52 WEEK LOW
9.95
MARKET CAP
1.75B
P/E (TTM)
-236.3768
1D
5D
1M
3M
1Y
5Y
1D
Biotech Stocks At 52-Week Highs - OABI +13%, FRNM, EXEL, FTH, LFST
NASDAQ · 4d ago
Elevance update guidelines cover Freenome CRC test, says Guggenheim
TipRanks · 6d ago
Cathie Wood's Ark weekly recap: Ark Invest boosts NVDA, AVGO as AMD leads sales
Seeking Alpha · 08/31 11:05
Weekly Report: what happened at FRNM last week (0824-0828)?
Weekly Report · 08/31 10:35
Gap Posts Upbeat Q2 Earnings, Joins Solstice Advanced Materials, N-Able And Other Big Stocks Moving Higher On Friday
Benzinga · 08/28 14:22
SpaceX continues to be Cathie's biggest bet; trims RBLX, PLTR, and AMD
Seeking Alpha · 08/24 11:07
Weekly Report: what happened at FRNM last week (0817-0821)?
Weekly Report · 08/24 10:36
Freenome Price Target Announced at $21.00/Share by Guggenheim
Dow Jones · 08/20 13:21
More
About FRNM
Freenome, Inc. is an early cancer detection company developing blood-based screening tests to identify cancer. The Company's proprietary multiomics discovery platform analyzes circulating cell-free DNA methylation patterns at single-base resolution alongside additional biomarkers to detect multiple cancers. The Company's development of SimpleScreen CRC for colorectal cancer screening, with clinical validation through the PREEMPT CRC Study, and a pipeline of tests for lung cancer and additional indications is designed to increase cancer screening participation. SimpleScreen CRC is a colorectal cancer screening test that uses a blood sample to look for signs of cancer and certain precancerous growths. The Company's platform integrates multiomics, artificial intelligence and machine learning to uncover complex biological signals associated with cancer.

Webull offers Freenome Inc stock information, including NASDAQ: FRNM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FRNM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FRNM stock methods without spending real money on the virtual paper trading platform.